Partial nephrectomy preserves renal function better than radical nephrectomy for complex tumors, especially in younger ...

In May 2025, the Journal for ImmunoTherapy of Cancer published a pioneering study entitled "NeoPred: dual-phase CT AI forecasts pathologic response to ...

Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, explains how the company partners with patient advocacy groups to identify unmet needs and prioritize patient-centered benefits in the ...

The company said the therapy is the first allogenic therapy developed with its Tmod technology to be tested in humans.

Verastem shows strong late-stage pipeline progress, financial discipline, and a diverse portfolio that support long-term ...

Tom Nolan reviews this week’s research A diagnostic accuracy study of a blood test for colorectal cancer has some promising, if paradoxical, findings. The cell free DNA test had an overall sensitivity ...

Adding nivolumab to neoadjuvant chemotherapy improved OS in patients with resectable NSCLC in the CheckMate 816 trial.